FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898844346> ?p ?o ?g. }

• W2898844346 abstract "Nodding syndrome (NS) is a devastating epileptic illness of unknown aetiology mainly affecting children 5-15 years of age. Head nodding distinguishes NS from other forms of epilepsy. Other manifestations of the illness include mental and physical growth retardation. Many children die as a result of falling in fires or drowning. Recently, it was shown that NS is only one of the phenotypic presentations of onchocerciasis associated epilepsy (OAE). Despite the strong epidemiological association between epilepsy and onchocerciasis, the causal mechanism is unknown. After implementation of bi-annual community directed treatment with ivermectin (CDTi) and larviciding of rivers in northern Uganda, new cases of NS have ceased, while new cases continue to emerge in South Sudanese onchocerciasis-endemic areas with an interrupted CDTi programme. This study is designed to evaluate the potential effects of bi-annual CDTi on reducing the incidence of NS/OAE in onchocerciasis-endemic areas in South Sudan.A pre-intervention door-to-door population-based household survey will be conducted in selected onchocerciasis-endemic villages in Mundri and Maridi Counties, which have a high prevalence of epilepsy. Using a validated questionnaire, the entire village will be screened by community research assistants for suspected epilepsy cases. Suspected cases will be interviewed and examined by a trained clinical officer or medical doctor who will confirm or reject the diagnosis of epilepsy. Bi-annual CDTi will be implemented in the villages and a surveillance system for epilepsy set up. By implementing an epilepsy onchocerciasis awareness campaign we expect to obtain > 90% CDTi coverage of eligible individuals. The door-to-door survey will be repeated two years after the baseline survey. The incidence of NS/OAE will be compared before and after bi-annual CDTi.Our study is the first population-based study to evaluate the effect of bi-annual CDTi to reduce the incidence of NS/OAE. If the study demonstrates such a reduction, these findings are expected to motivate communities in onchocerciasis-endemic regions to participate in CDTi, and will encourage policy makers, funders and other stakeholders to increase their efforts to eliminate onchocerciasis." @default.
• W2898844346 created "2018-11-09" @default.
• W2898844346 creator A5001957385 @default.
• W2898844346 creator A5006655563 @default.
• W2898844346 creator A5011712149 @default.
• W2898844346 creator A5016889135 @default.
• W2898844346 creator A5026030091 @default.
• W2898844346 creator A5027788051 @default.
• W2898844346 creator A5060090464 @default.
• W2898844346 creator A5063755588 @default.
• W2898844346 creator A5080091452 @default.
• W2898844346 date "2018-11-14" @default.
• W2898844346 modified "2023-10-12" @default.
• W2898844346 title "The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol" @default.
• W2898844346 cites W1160375105 @default.
• W2898844346 cites W1973981569 @default.
• W2898844346 cites W1978437325 @default.
• W2898844346 cites W1979411419 @default.
• W2898844346 cites W2001457674 @default.
• W2898844346 cites W2003288361 @default.
• W2898844346 cites W2005795852 @default.
• W2898844346 cites W2012453634 @default.
• W2898844346 cites W2029868978 @default.
• W2898844346 cites W2031615974 @default.
• W2898844346 cites W2048499352 @default.
• W2898844346 cites W2071253622 @default.
• W2898844346 cites W2077519968 @default.
• W2898844346 cites W2081723126 @default.
• W2898844346 cites W2112817270 @default.
• W2898844346 cites W2114282456 @default.
• W2898844346 cites W2140527299 @default.
• W2898844346 cites W2162734057 @default.
• W2898844346 cites W2244097366 @default.
• W2898844346 cites W2247657883 @default.
• W2898844346 cites W2255896550 @default.
• W2898844346 cites W2304118135 @default.
• W2898844346 cites W2304706004 @default.
• W2898844346 cites W2406804354 @default.
• W2898844346 cites W2587837928 @default.
• W2898844346 cites W2734326978 @default.
• W2898844346 cites W2781158168 @default.
• W2898844346 cites W4234421278 @default.
• W2898844346 doi "https://doi.org/10.1186/s40249-018-0496-2" @default.
• W2898844346 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6234538" @default.
• W2898844346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30424817" @default.
• W2898844346 hasPublicationYear "2018" @default.
• W2898844346 type Work @default.
• W2898844346 sameAs 2898844346 @default.
• W2898844346 citedByCount "14" @default.
• W2898844346 countsByYear W28988443462018 @default.
• W2898844346 countsByYear W28988443462019 @default.
• W2898844346 countsByYear W28988443462020 @default.
• W2898844346 countsByYear W28988443462021 @default.
• W2898844346 countsByYear W28988443462022 @default.
• W2898844346 countsByYear W28988443462023 @default.
• W2898844346 crossrefType "journal-article" @default.
• W2898844346 hasAuthorship W2898844346A5001957385 @default.
• W2898844346 hasAuthorship W2898844346A5006655563 @default.
• W2898844346 hasAuthorship W2898844346A5011712149 @default.
• W2898844346 hasAuthorship W2898844346A5016889135 @default.
• W2898844346 hasAuthorship W2898844346A5026030091 @default.
• W2898844346 hasAuthorship W2898844346A5027788051 @default.
• W2898844346 hasAuthorship W2898844346A5060090464 @default.
• W2898844346 hasAuthorship W2898844346A5063755588 @default.
• W2898844346 hasAuthorship W2898844346A5080091452 @default.
• W2898844346 hasBestOaLocation W28988443461 @default.
• W2898844346 hasConcept C107130276 @default.
• W2898844346 hasConcept C118552586 @default.
• W2898844346 hasConcept C120665830 @default.
• W2898844346 hasConcept C121332964 @default.
• W2898844346 hasConcept C138816342 @default.
• W2898844346 hasConcept C142724271 @default.
• W2898844346 hasConcept C165901193 @default.
• W2898844346 hasConcept C17744445 @default.
• W2898844346 hasConcept C187212893 @default.
• W2898844346 hasConcept C199539241 @default.
• W2898844346 hasConcept C203014093 @default.
• W2898844346 hasConcept C2777499811 @default.
• W2898844346 hasConcept C2777629521 @default.
• W2898844346 hasConcept C2778182931 @default.
• W2898844346 hasConcept C2778186239 @default.
• W2898844346 hasConcept C2780727990 @default.
• W2898844346 hasConcept C2908647359 @default.
• W2898844346 hasConcept C42972112 @default.
• W2898844346 hasConcept C61511704 @default.
• W2898844346 hasConcept C71924100 @default.
• W2898844346 hasConcept C99454951 @default.
• W2898844346 hasConceptScore W2898844346C107130276 @default.
• W2898844346 hasConceptScore W2898844346C118552586 @default.
• W2898844346 hasConceptScore W2898844346C120665830 @default.
• W2898844346 hasConceptScore W2898844346C121332964 @default.
• W2898844346 hasConceptScore W2898844346C138816342 @default.
• W2898844346 hasConceptScore W2898844346C142724271 @default.
• W2898844346 hasConceptScore W2898844346C165901193 @default.
• W2898844346 hasConceptScore W2898844346C17744445 @default.
• W2898844346 hasConceptScore W2898844346C187212893 @default.
• W2898844346 hasConceptScore W2898844346C199539241 @default.
• W2898844346 hasConceptScore W2898844346C203014093 @default.
• W2898844346 hasConceptScore W2898844346C2777499811 @default.
• W2898844346 hasConceptScore W2898844346C2777629521 @default.

• next